SCHEMBL20181907

SCHEMBL20181907

CC(/C(=C/Nc1ccccc1F)N=N)n1cc(C2CCC2)c2c(N)ncnc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.35
TEK Q02763 2/20 0.35
ERBB2 P04626 1/20 0.35
ERBB3 P21860 1/20 0.35
ERBB4 Q15303 1/20 0.35
PDPK1 O15530 3/20 0.34
METTL3 Q86U44 10/20 0.33
PRMT5 O14744 3/20 0.33
RET P07949 3/20 0.33
SRC P12931 2/20 0.32
ABL1 P00519 1/20 0.32
ABL2 P42684 1/20 0.32
AKT1 P31749 1/20 0.32
MTOR P42345 1/20 0.32
WDR77 Q9BQA1 1/20 0.32
NTRK1 P04629 1/20 0.32
NTRK3 Q16288 1/20 0.32
NTRK2 Q16620 1/20 0.32
LCK P06239 1/20 0.31
KDR P35968 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20181904 0.97 PDPK1 (0.36) EGFRTEKERBB2ERBB3ERBB4
SCHEMBL20182295 0.91 MTOR (0.33) EGFRTEKERBB2ERBB3ERBB4
SCHEMBL20182234 0.86 EGFR (0.35) EGFRTEKERBB2ERBB3ERBB4
SCHEMBL20182202 0.81
SCHEMBL20182228 0.80 KDR (0.45) EGFRTEKSRCMTORLCK
SCHEMBL20182283 0.80 NTRK1 (0.36) EGFRTEKERBB2ERBB3ERBB4
SCHEMBL20182200 0.79 KDR (0.39) TEKSRCLCKKDR
SCHEMBL20182362 0.79 CFTR (0.40) EGFRTEKRETSRCABL1
SCHEMBL20182274 0.78 EIF2AK3 (0.40) EGFRTEKRETSRCLCK
SCHEMBL20182241 0.77 KDR (0.46) EGFRTEKSRCABL1ABL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed